Skip to main content

Net Worth Advisory Group

SEC CIK
0001791998
Latest filing
Jul 13, 2026

STOK holding history

Stoke Therapeutics, Inc. in every 13F filed by Net Worth Advisory Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

STOK overviewAll 13F holders of STOKFull Q2 2026 holdings

Shares (Q2 2025)
0
Sold out in Q2 2025
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q1 2025
Holdings of STOK by Net Worth Advisory Group, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20250$00.0%−20,741−100.0%Sold outHolders
Q1 202520,741$137.7K<0.1%+20,741NewHolders